Medical resources and spending across provincial healthcare systems in Canada.

Download Full Article Article Brief

Summary

EN/FR

This study compares the availability of medical resources and government health expenditure across provinces in 2017; and tests for statistical correlations between the variables. The analysis links the availability of new drugs to lower overall health expenditures. Policy implications for pharmacare, PMPRB regulatory changes, public drug plans and silo-based health budgets are briefly discussed.

CHP blogazine

National pharmacare advisory council’s report leaves many unanswered questions.

By Nigel SB Rawson, Ph.D. The 2019 federal budget announced that the government will take »

Opinions

Proposed new drug regulations will hurt all Canadians.

Nigel Rawson | Financial Post | August 13, 2019 Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned. Opinion: Changes which aim to make prescriptions more affordable could shut off entry of new drugs. »
Don't blow up pharmacare as we know it. Just fill the gaps.

Brett Skinner | Financial Post | June 25, 2019 »
Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway.

Brett Skinner | Financial Post | Feb 28, 2019 »

News

Health Canada requires hospitals to report adverse drug reactions and medical device incidents.

Health Canada recently announced new regulations t »
CADTH and BC Pharmacare move to ease entry of biosimilar drugs.

The Canadian Agency for Drugs and Technologies in »
Council on the Implementation of National Pharmacare releases final report.

The federal Council on the Implementation of Natio »

Medical resources and spending across provincial healthcare systems in Canada.

Summary

EN/FR

Choose an option to continue...

Get Article

Subscribe

Membership

Log in

Log in

Register